Pharma BD Deal Intelligence
Novartis AG / Selexys Pharmaceuticals
2002 · Acquisition/Merger · $665M · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
37
Underwhelmed — fell short of the thesis.
Novartis acquired Selexys Pharmaceuticals for $665M for hematology therapies.
Key facts
- Announced Dec 18, 2002
- Closed Nov 18, 2016
- Deal value $665M
- Deal type Acquisition/Merger
- Therapeutic area Hematology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals